Tribolium castaneum defensin 1 kills Moraxella catarrhalis in an in vitro infection model but does not harm commensal bacteria
Open Access
- 12 April 2021
- journal article
- research article
- Published by Taylor & Francis in Virulence
- Vol. 12 (1) , 1003-1010
Abstract
Moraxella catarrhalis is a bacterial pathogen that causes respiratory tract infections in humans. The increasing prevalence of antibiotic-resistant M. catarrhalis strains has created a demand for alternative treatment options. We therefore tested 23 insect antimicrobial peptides (AMPs) for their activity against M. catarrhalis in a human in vitro infection model with primary macrophages, and against commensal bacteria. Effects on bacterial growth were determined by colony counting and growth curve analysis. The inflammatory macrophage response was characterized by qPCR and multiplex ELISA. Eleven of the AMPs were active against M. catarrhalis. Defensin 1 from the red flour beetle Tribolium castaneum significantly inhibited bacterial growth and reduced the number of colony forming units. This AMP also showed antibacterial activity in the in vitro infection model, reducing cytokine expression and release by macrophages. Defensin 1 had no effect on the commensal bacteria Escherichia coli and Enterococcus faecalis. However, sarcotoxin 1 C from the green bottle fly Lucilia sericata was active against M. catarrhalis and E. coli, but not against E. faecalis. The ability of T. castaneum defensin 1 to inhibit M. catarrhalis but not selected commensal bacteria, and the absence of cytotoxic or inflammatory effects against human blood-derived macrophages, suggests this AMP may be suitable for development as a new therapeutic lead against antibiotic-resistant M. catarrhalis.Keywords
Funding Information
- German Center for Infectious Disease Research
- Hessisches Ministerium für Wissenschaft und Kunst
This publication has 25 references indexed in Scilit:
- Antibacterial activity of a Tribolium castaneum defensin in an in vitro infection model of Streptococcus pneumoniaeVirulence, 2019
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2019
- Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolutionScientific Reports, 2018
- Antibiotic-Induced Changes in the Intestinal Microbiota and DiseaseTrends in Molecular Medicine, 2016
- Antimicrobial Peptides Expressed in Medicinal Maggots of the Blow Fly Lucilia sericata Show Combinatorial Activity against BacteriaAntimicrobial Agents and Chemotherapy, 2015
- The expanding scope of antimicrobial peptide structures and their modes of actionTrends in Biotechnology, 2011
- Moraxella catarrhalis,a Human Respiratory Tract PathogenClinical Infectious Diseases, 2009
- Moraxella catarrhalis: from Emerging to Established PathogenClinical Microbiology Reviews, 2002
- Spectrum and Significance of Bacteremia Due to Moraxella catarrhalisClinical Infectious Diseases, 1995
- Rank Methods for Combination of Independent Experiments in Analysis of VarianceThe Annals of Mathematical Statistics, 1962